Acumed | OsteoMed Launches PFX Choice Customer Service Program
PFX Choice is designed to help customers choose the right combination of products, customer service, payment and billing options....
Aug 20, 2021,
Acumed | OsteoMed Launches PFX Choice Customer Service Program
Surgalign Issued Patent for AI in Medical Image Segmentation
The machine learning system is part of HOLO AI, Surgalign’s core technology in artificial intelligence and augmented reality....
Aug 20, 2021,
Conformis Reports First Case with the Identity Imprint Knee
Identity Imprint, available in cruciate retaining and posterior stabilized versions, uses a proprietary algorithm to select the implant size....
Aug 19, 2021,
4 Orthopedic Companies New on Our Radar
I’m very interested in sharing companies that we learn about throughout our daily research. Here we meet four from around...
Aug 18, 2021,
Executives Talk the Past, Present and Future of Robotics
Technology updates, the competitive landscape and surgeon and patient interest are pushing orthopedic companies to speed robotic iterations and innovations....
Aug 18, 2021,
Mirus Announces Large Funding Round to Expand Spine Portfolio
The announcement is the largest publicly disclosed funding we can remember in recent years....
Aug 18, 2021,
What Orthopedic Executives Said About 2Q21
Second-quarter commentary from ortho executives focused on acquisitions, knee replacement sales performance and enabling technology’s impact....
Aug 18, 2021,
Medartis Advances Strategic Expansion in US Market
The company grew nearly 30% in the first half of 2021, with important contributions coming from its growing presence in...
Aug 18, 2021,
Zimmer Biomet Gains FDA Clearance for ROSA Hip System
ROSA Hip and ONE Planner Hip complement current robotic solutions for total and partial knee replacement....
Aug 18, 2021,
DePuy Synthes Introduces the INHANCE Shoulder Replacement
The INHANCE Shoulder can treat a broad range of cases, and is suitable for hospitals as well as outpatient and...
Aug 18, 2021,
Loading new posts...
No more posts
